Pharvaris (PHVS) EPS (Basic) Growth (1y) (2021 - 2026)
Pharvaris (PHVS) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | 21.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.86% |
| Dec 31, 2025 | -32.77% |
| Sep 30, 2025 | 17.86% |
| Jun 30, 2025 | 59.62% |
| Mar 31, 2025 | -58.61% |
| Dec 31, 2024 | 25.10% |
| Sep 30, 2024 | -35.22% |
| Jun 30, 2024 | -14.04% |
| Mar 31, 2024 | 21.35% |
| Dec 31, 2023 | 23.25% |
| Sep 30, 2023 | -154.17% |
| Jun 30, 2023 | 70.85% |
| Mar 31, 2023 | -32.54% |
| Dec 31, 2022 | -100.00% |
| Sep 30, 2022 | 46.65% |
| Jun 30, 2022 | 135.63% |
| Mar 31, 2022 | 32.22% |
| Dec 31, 2021 | 43,999,950.27% |
| Sep 30, 2021 | 69.95% |
| Jun 30, 2021 | 13.14% |